Watson Laboratories recalls

Watson Laboratories has 22 recalls on record with the FDA and USDA, the earliest in 2012 and the latest reported on 5 Feb 2014. The most frequent reason is packaging defects.

Total recalls22since 2012
Last 12 months0reported
Class I15% of total
Ongoing0latest 5 Feb 2014

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 1 5%Class II 12 55%Class III 9 41%

Why watson laboratories is recalled

By year

All watson laboratories recalls, newest first

22 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIHydrocodone Bitartrate and Acetaminophen Tablets USP, CIII recalledWatson LaboratoriesOtherNationwide
DrugCLASS IICarisoprodol Tablets, USP, CIV, 350 mg recalled by Watson LaboratoriesWatson LaboratoriesParticulate MatterNationwide
DrugCLASS IINext Choice" One Dose Emergency Contraceptive recalledWatson LaboratoriesOtherNationwide
DrugCLASS IIOxycodone and Acetaminophen Tablets, USP 10 mg/650 mg, CII recalledWatson LaboratoriesPackaging DefectsNationwide
DrugCLASS IIIHydrocodone Bitartrate and Acetaminophen Tablets, 7.5 mg recalledWatson LaboratoriesPackaging DefectsNationwide
DrugCLASS IIIOxycodone and Acetaminophen Capsules, USP 5mg/500 mg recalledWatson LaboratoriesPotency & AssayNationwide
DrugCLASS IIZarah¿ Drospirenone/ Ethinyl Estradiol Tablets, 3.0 mg/0.03 mg recalledWatson LaboratoriesOtherNationwide
DrugCLASS IIMeprobamate; Tablets USP, 400 mg recalled by Watson LaboratoriesWatson LaboratoriesPotency & AssayNationwide
DrugCLASS IIMeprobamate, Tablets USP, 200 mg recalled by Watson LaboratoriesWatson LaboratoriesPotency & AssayNationwide
DrugCLASS IIICaziant (desogestrel and ethinyl estradiol) Tablets recalledWatson LaboratoriesPotency & AssayNationwide
DrugCLASS IHydrocodone Bitartrate and Acetaminophen Tablets USP, 10 mg recalledWatson LaboratoriesPotency & AssayNationwide
DrugCLASS IIZenchent (norethindrone and ethinyl estradiol) Tablets USP, 0.4 mg/0 recalledWatson LaboratoriesPackaging DefectsNationwide
DrugCLASS IINecon 1/35-28 (norethindrone recalled by Watson LaboratoriesWatson LaboratoriesPackaging DefectsNationwide
DrugCLASS IILutera (levonorgestrel and ethinyl estradiol) Tablets recalledWatson LaboratoriesPackaging DefectsNationwide
DrugCLASS IIZovia (ethynodiol diacetate recalled by Watson LaboratoriesWatson LaboratoriesPackaging DefectsNationwide
DrugCLASS IINecon 10/11 (norethindrone and ethinyl estradiol) Tablets recalledWatson LaboratoriesPackaging DefectsNationwide
DrugCLASS IIICaziant (desogestrel and ethinyl estradiol) Tablets recalledWatson LaboratoriesPotency & AssayNationwide
DrugCLASS IIILoxitane Capsules, Loxapine Succinate Capsules, 10mg base recalledWatson LaboratoriesPackaging DefectsNationwide
DrugCLASS IIILoxapine Capsules USP, 25mg recalled by Watson LaboratoriesLoxapineWatson LaboratoriesPackaging DefectsNationwide
DrugCLASS IIILoxapine Capsules USP, 10mg recalled by Watson LaboratoriesLoxapineWatson LaboratoriesPackaging DefectsNationwide
DrugCLASS IIILoxapine Capsules USP, 50mg recalled by Watson LaboratoriesLoxapineWatson LaboratoriesPackaging DefectsNationwide
DrugCLASS IIILoxapine Capsules USP, 5mg recalled by Watson LaboratoriesWatson LaboratoriesPackaging DefectsNationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.